PCV14 A COMPARISON OF THE RISK OF ADVERSE THROMBOEMBOLIC AND BLEEDING EVENTS BETWEEN SUBJECTS TREATED AND NOT TREATED WITH WARFARIN
Abstract
Authors
A Riedel O Hauch C Harley M Nelson G Wygant MW Reynolds
A Riedel O Hauch C Harley M Nelson G Wygant MW Reynolds
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now